Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.
Suzukawa M, Ohta K, Sugimoto M, Ohshima N, Kobayashi N, Tashimo H, Tanimoto Y, Itano J, Kimura G, Takata S, Nakano T, Yamashita T, Ikegame S, Hyodo K, Abe M, Chibana K, Kamide Y, Sasaki K, Hashimoto H. Suzukawa M, et al. Among authors: chibana k. Allergol Int. 2024 Apr 23:S1323-8930(24)00047-9. doi: 10.1016/j.alit.2024.04.003. Online ahead of print. Allergol Int. 2024. PMID: 38658257 Free article.
Corrigendum to "Transcutaneous gas monitoring is a useful tool to detect respiratory depression during bronchoscopy performed under propofol sedation" [Resp. Invest. 61 (2023) 793-799].
Yazawa N, Nakamura Y, Takemasa A, Uchida N, Kushima Y, Masawa M, Okutomi H, Soda S, Ikeda N, Arai R, Chibana K, Niho S, Shimizu Y. Yazawa N, et al. Among authors: chibana k. Respir Investig. 2024 Mar;62(2):295. doi: 10.1016/j.resinv.2024.01.007. Epub 2024 Jan 30. Respir Investig. 2024. PMID: 38295612 No abstract available.
Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L).
Ozawa Y, Koh Y, Hase T, Chibana K, Kaira K, Okishio K, Ichihara E, Murakami S, Shimokawa M, Yamamoto N. Ozawa Y, et al. Among authors: chibana k. Ther Adv Med Oncol. 2024 Jan 27;16:17588359231225046. doi: 10.1177/17588359231225046. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38282663 Free PMC article.
[Orexin].
Chibana K. Chibana K. Arerugi. 2023;72(9):1176-1177. doi: 10.15036/arerugi.72.1176. Arerugi. 2023. PMID: 37967965 Japanese. No abstract available.
Changes in Peripheral Blood Eosinophil Counts and Risk of Eosinophilic Granulomatosis with Polyangiitis Onset after Initiation of Dupilumab Administration in Adult Patients with Asthma.
Kushima Y, Shimizu Y, Hoshi H, Arai R, Ikeda N, Nakamura Y, Masawa M, Okutomi H, Yazawa N, Chibana K, Takemasa A, Niho S. Kushima Y, et al. Among authors: chibana k. J Clin Med. 2023 Sep 1;12(17):5721. doi: 10.3390/jcm12175721. J Clin Med. 2023. PMID: 37685789 Free PMC article.
Prophylactic treatment of dacomitinib-induced skin toxicities in epidermal growth factor receptor-mutated non-small-cell lung cancer: A multicenter, Phase II trial.
Iwasaku M, Uchino J, Chibana K, Tanzawa S, Yamada T, Tobino K, Uchida Y, Kijima T, Nakatomi K, Izumi M, Tamiya N, Kimura H, Fujita M, Honda R, Takumi C, Yamada T, Kaneko Y, Kiyomi F, Takayama K. Iwasaku M, et al. Among authors: chibana k. Cancer Med. 2023 Jul;12(14):15117-15127. doi: 10.1002/cam4.6184. Epub 2023 Jun 3. Cancer Med. 2023. PMID: 37269194 Free PMC article. Clinical Trial.
Clinical impact of amrubicin monotherapy in patients with relapsed small cell lung cancer: a multicenter retrospective study.
Uda S, Yamada T, Yoshimura A, Goto Y, Yoshimine K, Nakamura Y, Shiotsu S, Yokoi T, Tamiya N, Kimura H, Chihara Y, Umeda Y, Izumi M, Takeda T, Yamada T, Hibino M, Hiranuma O, Ito K, Okada A, Osugi S, Takemura Y, Ishii H, Chibana K, Hasegawa I, Morimoto Y, Iwasaku M, Tokuda S, Takayama K. Uda S, et al. Among authors: chibana k. Transl Lung Cancer Res. 2022 Sep;11(9):1847-1857. doi: 10.21037/tlcr-22-160. Transl Lung Cancer Res. 2022. PMID: 36248326 Free PMC article.
Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study).
Suzukawa M, Ohta K, Fukutomi Y, Hashimoto H, Endo T, Abe M, Kamide Y, Yoshida M, Kikuchi Y, Kita T, Chibana K, Tanimoto Y, Hyodo K, Takata S, Inui T, Yasui M, Harada Y, Sato T, Sakakibara Y, Minakata Y, Inoue Y, Tamaki S, Shinohara T, Takami K, Tsubakihara M, Oki M, Wakamatsu K, Horiba M, Ideura G, Hidaka K, Saito AM, Kobayashi N, Taniguchi M. Suzukawa M, et al. Among authors: chibana k. Allergol Int. 2023 Jan;72(1):63-74. doi: 10.1016/j.alit.2022.06.002. Epub 2022 Jul 2. Allergol Int. 2023. PMID: 35791991 Free article.
Soluble ST2 enhances IL-33-induced neutrophilic and pro-type 2 inflammation in the lungs.
Watanabe M, Nakamoto K, Inui T, Sada M, Chibana K, Miyaoka C, Yoshida Y, Aso J, Nunokawa H, Honda K, Nakamura M, Tamura M, Hirata A, Oda M, Takata S, Saraya T, Kurai D, Ishii H, Takizawa H. Watanabe M, et al. Among authors: chibana k. Allergy. 2022 Oct;77(10):3137-3141. doi: 10.1111/all.15401. Epub 2022 Jun 16. Allergy. 2022. PMID: 35661175 Free PMC article. No abstract available.
45 results